The general mood among these heavyweight investors is divided, with 62% leaning bullish and 37% bearish. Among these notable ...

So far, 2025 hasn't been the best year for stocks. Investors are understandably jittery and on the sidelines with on-again, off-again policy changes, trade wars, broken alliances, and interest rate ...

An in-depth analysis of recent analyst actions unveils how financial experts perceive CVS Health. The following summary ...

Good day, and welcome to ARS Pharmaceuticals fourth quarter and full year 2024 financial results conference call. (Operator Instructions) As a reminder, this call is being recorded. I would now like ...

The PBM plans to stop requiring coverage reauthorization for about 80 drugs, including Vertex’s cystic fibrosis medicines and ...

The massive pharmacy benefit manager plans to stop requiring coverage reauthorizations for roughly 80 drugs used to treat ...

Current and former employees are suing JPMorgan, alleging that it allows inflated drug prices through its partnership with ...

A sign posted recently on the CVS Pharmacy and store at 3890 Phelan Blvd. states it will close on April 10. The notice did ...

Deep-pocketed investors have adopted a bearish approach towards CVS Health (NYSE:CVS), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga ...

CVS locations on Raeford Road, Cliffdale Road and Ramsey Street will close as part of a nationwide downsizing by CVS Health. Prescriptions from the closing locations will be transferred to other ...

TikTok has become home to all sorts of handy hacks, interesting stories and funny clips, but it's also a place for learning. One particular educational clip centers around the meaning of the acronym ...

CVS Health experienced a significant share price decline in 2024, driven by earnings misses, CEO departure, and regulatory pressures on its PBM and Medicare Advantage businesses. Q4 2024 earnings ...